RT Book, Section
A1 May, J. Russell
A1 Griffin, Dixie D.
A1 May, Kathleen
A2 Chisholm-Burns, Marie A.
A2 Schwinghammer, Terry L.
A2 Malone, Patrick M.
A2 Kolesar, Jill M.
A2 Bookstaver, P. Brandon
A2 Lee, Kelly C.
SR Print(0)
ID 1187023989
T1 Drug Hypersensitivity Reactions
T2 Pharmacotherapy Principles & Practice, 6e
YR 2022
FD 2022
PB McGraw-Hill Education
PP New York, NY
SN 9781260460278
LK ppp.mhmedical.com/content.aspx?aid=1187023989
RD 2024/10/06
AB LEARNING  OBJECTIVESUpon  completion  of  the  chapter,  the  reader  will  be  able  to:Describe  the  potential  incidence  of  immunoglobulin-E  (IgE)-  and  non-IgE-mediated  (immune  and  nonimmune)  drug  hypersensitivity  reactions  and  why  it  is  difficult  to  obtain  accurate  estimates.Understand  the  Gell  and  Coombs  categories  of  immunologic  reactions  and  more  recently  described  immunologic  mechanisms.Identify  the  classes  of  drugs  most  commonly  associated  with  IgE-  and  non–IgE-mediated  drug  hypersensitivity  reactions.Recommend  specific  treatment  for  anaphylaxis.Recommend  an  approach  to  drug  selection  in  patients  with  multiple  drug  sensitivities.Understand  the  utility  of  drug  challenge  and  desensitization  procedures.